INKT
MiNK Therapeutics, Inc.
$10.62
-0.94 (-8.13%)
At close · Jul 7
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the completion of anticipated funding is not entirely within the Company’s control, the Company is required to disclose that substantial doubt exists about its ability to continue as a going concern for a period of one year after the date of filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed May 15, 2026
Market Cap
$52.56M
Shares
4,981,899
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$12.49M
-15.9%
FY2025
Diluted EPS
-$2.93
-2.4%
FY2025
Operating Cash Flow
-$5.93M
+38%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $247.56K | $180.25K | $172.57K | $463.26K | $253.32K | -$2.43M | — | |
| $5.7M | $5.76M | $6.34M | $15.49M | $23.12M | $13.97M | $9.51M | |
| $7.14M | $6.73M | $4.31M | $7.43M | $7.83M | $4.64M | $1.29M | |
| -$12.82M | -$12.64M | -$11.29M | -$22.92M | -$30.95M | -$28.36M | -$14.64M | |
| -$85K | -$110K | -$93K | -$28K | — | $2.43M | $2.44M | |
| $105.74K | -$32.37K | $330.92K | -$10 | $2.7M | $221.92K | $839.19K | |
| -$12.47M | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M | -$16.24M | |
| -$12.5M | -$12.58M | -$10.99M | -$22.6M | -$27.66M | -$29.32M | -$17.63M | |
| USD/shares | — | -$2.93 | -$2.86 | -$6.54 | -$8.30 | -$11.60 | — |
| USD/shares | — | -$2.93 | -$2.86 | -$6.54 | -$8.30 | -$11.60 | — |
| shares | — | 4.27M | 3.77M | 3.44M | 3.37M | 2.6M | 2.41M |
| shares | — | 4.27M | 3.77M | 3.44M | 3.37M | 2.6M | 2.41M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.